(GLOBE NEWSWIRE via COMTEX) –Trust furthers commitment to integration and interoperability with Allscripts Sunrise(TM)
LIVERPOOL, United Kingdom, Sept. 28, 2017 (GLOBE NEWSWIRE) — Liverpool Heart and Chest Hospital NHS Foundation Trust (LHCH), selected Allscripts (NASDAQ:MDRX) as its future partner for another five consecutive years with an expanded use of Sunrise suite of electronic patient record (EPR) solutions. The contract was signed in the second quarter of 2017.
Liverpool Heart and Chest Hospital provides specialist services in cardiothoracic surgery, cardiology, respiratory medicine including adult cystic fibrosis, and diagnostic imaging, both in the hospital and throughout the community. The Trust serves an area of 2.8 million people, spanning Merseyside, Cheshire, North Wales and the Isle of Man. LHCH first deployed the Sunrise suite of solutions in 2013 and is already paperless in most areas. Since EPR was deployed, the hospital has been rated one of the top Trusts for Clinical Digital Maturity Index (CDMI), a benchmarking tool that indicates the Trusts ability to effectively use information technology to improve patient safety and outcomes. LHCH is the first specialist Trust in the United Kingdom, Chesire and Merseyside to be rated as Outstanding by the Care Quality Commission.
“At LHCH, coordinated integration and interoperability via a common record with a single vendor is an important goal,” said Head of Digital Healthcare at LHCH, David Murphy. “We have had tremendous success with Sunrise and look forward to continuing to partner with Allscripts to remain at the forefront of digitally-enabled healthcare.”
Allscripts Sunrise is a fully-integrated platform that supports all core care venues with a single platform and single patient record. The solution comprises functionality spanning investigation requests and results, clinical documentation, electronic prescribing and medicines administration to clinical decision support and workflow management. These features are used across inpatient and outpatient settings optimising the delivery of safe and efficient care.
The use of Sunrise at LHCH has contributed to many benefits including supporting a sustained 63% reduction in hospital acquired pressure ulcers and enhanced infection control through standardised documentation and audit tools.
“Allscripts EPR improves patient safety when clinically checking a patient’s prescription as all the relevant clinical data is available to view from any terminal in the hospital,” said Senior Clinical Pharmacist at LHCH, Cassie Cordner.
“LHCH have optimised the Sunrise suite of solutions to deliver exceptional care on paperless wards,” said Vice President and Managing Director of Allscripts UK, Steve Brain. “I am delighted that LHCH re-committed to remain with Allscripts for another 5 years and to continue the strong partnership. We are committed to assisting LHCH with their mission to improve Quality and Patient Experience, supporting the Enhancement of Service Delivery, Research and Innovation to help drive their vision “to be the best – leading and delivering outstanding heart and chest care and research”.
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health(TM). Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTubeand It Takes A Community: The Allscripts Blog.
© 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Allscripts via Globenewswire